Arris Pharmaceuticals

Products/technologies Formerly Arris Pharmaceutical Corp., the company announced in January 1998 its plans to commercialize its capabilities in combinatorial chemistry and pharmacogenomics as well as its patented technology. The company licenses its combinatorial chemistry technology to pharmaceutical and biotech companies, and collaborates with companies wishing to screen its libraries. 

Merritt et al. [1] and others [15] have disclosed a number of techniques for parallel phase separation which facilitates the aqueous washing of crude products. The initial approach used a commercially available hydrophobic membrane in a polypropylene cartridge to separate a chlorinated solvent from an aqueous phase. An alternative liquid solid extraction involving an absorbent packing has also been used by workers at Arris Pharmaceuticals in the preparation of triazine libraries [16]. 

Asked what he thought the initial expectations for genomic data were, Dr Michael C. Venuti, former head of research at Arris (later Axys) Pharmaceuticals, and now CEO of BioSeek, put it wryly. I think everyone in biotech and pharma hoped that we would take out our secret decoder ring and there d be all kinds of things in there that would be obvious if we turned on our computers at the right time of day, he said. I think everyone eventually came to the realization that it s what everyone did with the information that matters, and it s still what anyone does with the information that matters. ... 

---